---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-24-000036"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T13:57:54.399117+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Sotera Health appoints Christopher A. Simon to board of directors

## Summary
- Board increased from 11 to 12 directors; Simon appointed as Class III director effective August 1, 2024.
- Simon is President & CEO of Haemonetics Corporation and will serve on the Leadership Development and Compensation Committee.
- Simon is independent under Nasdaq Rule 5605(a)(2); no arrangement or reportable transactions with the company.
- As non-employee director, Simon will receive standard cash retainer and annual restricted stock unit grant.

## SEC filing metadata
- accession: 0001822479-24-000036
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000036/0001822479-24-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000036/shc-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-24-000036
- JSON: https://secwatch.observer/filing/0001822479-24-000036.json
- Plain text: https://secwatch.observer/filing/0001822479-24-000036.txt

## Key facts
- Executive change
  Christopher A. Simon was appointed as Class III director at Sotera Health Co.
  - Action: appointed
  - Role: Class III director
  source text: On July 31, 2024, the Board of Directors (the “Board”) of Sotera Health Company (the “Company”) increased the size of the Board from eleven directors to twelve directors and appointed Christopher A. Simon as a Class III director of the Board, effective August 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000036/0001822479-24-000036-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.